摘要
目的研究和分析半夏厚朴汤治疗咳嗽变异性哮喘的临床疗效。方法选取该院2017年2月—2018年2月收治的92例变异性哮喘作为主要研究对象,46例被命名为对照组的变异性哮喘患者沙美特罗替卡松粉吸入剂治疗,46例被命名为观察组的变异性哮喘患者采用半夏厚朴汤联合沙美特罗替卡松粉吸入剂治疗,根据两组患者的临床治疗数据分析半夏厚朴汤的优越性。结果对照组愈显率为60.87%,总有效率为80.43%;观察组愈显率为91.30%,总有效率为93.48%,两组对比差异有统计学意义(χ~2=25.445、7.507,P=0.006,);观察组咳嗽减轻时间、咳嗽消退时间、夜咳停止时间与对照组相比更优,差异有统计学意义(t=8.208、5.849、10.605,P=0.000、0.006);两组患者治疗后症状对比观察组差异有统计学意义(t=4.771,P<0.05);两组阳性例数、转阴例数对比观察组差异有统计学意义(χ~2=0.417、18.852,P<0.05);两组患者治疗前EOS、IL-13对比差异无统计学意义(t=0.025、2.201,P=0.981、0.030,P>0.05),观察组治疗后EOS、IL-13对比显著优于对照组,差异有统计学意义(t=2.201、3.136,P=0.702、0.002)。结论在变异性哮喘的临床治疗中,半夏厚朴汤不仅能有效的改善患者的临床疗效,还能有效的降低并发症发生率,有良好的的临床应用价值。
Objective To study and analyze the clinical efficacy of Banxiahoupu Decoction in the treatment of cough variant asthma.Methods 92 cases of variability asthma admitted in the hospital from February 2017 to February 2018 were selected as the main re-search subjects. 46 patients were treated with salmeterol inhalation inhalation in the control group of variability asthma patients, and46 patients with variability asthma in the observation group were treated with Banxiahoupu Decoction combined with salmeteroltere-sapine inhaler. According to clinical treatment data of the two groups of patients, the superiority of Banxiahoupu Decoction was ana-lyzed. Results The effective rate of the control group was 60.87%, and the total effective rate was 80.43%; the observed rate of the ob-servation group was 91.30%, and the total effective rate was 93.48%. The comparison between the two groups was statistically signifi-cant（χ^2=25.445,7.507, P=0.006, P〈0.05）; The observation group had better time for cough reduction, time for cough resolving, and time for stopping coughing than those in the control group（t=8.208, 5.849, 10.605,P=0.000,0.006,P〈0.05）; The group was better and statistically significant（t=4.771,P〈0.05）; the number of positive cases and negative cases in the two groups was better than the observation group, with statistical significance（χ^2=0.417, 18.852, P〈0.05）; EOS and IL-13 were not statistically significant before treatment in the two groups（t=0.025, 2.201, P=0.981,0.030,P〈0.05）. EOS and IL-13 The contrast was significantly better than the control group（t=2.201, 3.136, P=0.702, 0.002）. Conclusion In the clinical treatment of variant asthma, Banxiahoupu Decoction can not only effectively improve the clinical efficacy of patients, but also effectively reduce the incidence of complications, and has good clinical application value.
作者
盛梅
SHENG Mei(Department of Geriatrics（Health Section）Heze Hospital of Traditional Chinese Medicine,Heze,Shandong Province,274000 China)
出处
《世界复合医学》
2018年第3期69-71,共3页
World Journal of Complex Medicine
关键词
半夏厚朴汤
变异性哮喘
临床疗效
治疗效果
Banxiahoupu Decoction
Variant asthma
Clinical efficacy
Therapeutic effect
